International Medicine (000516) announced a share repurchase announcement on May 21abugarciacardinalc3spinningreel, the company plans to complete this company's share repurchase plan from May 21, 2024 to May 20, 2025, and the repurchase price will not exceed 9abugarciacardinalc3spinningreel.16 yuan/share, and the total repurchase amount shall not exceed RMB 15,000abugarciacardinalc3spinningreel.00 million yuan. If it is fully repurchased and calculated based on the upper limit of the total repurchase amount and the upper limit of the repurchase share price, it is estimated that the number of shares that can be repurchased will not exceed 16.3755 million shares. The upper limit of the number of shares to be repurchased will account for the company's total share capital. It is 0.72%, and the specific number of shares repurchased shall be based on the actual number of shares repurchased when the repurchase expires or terminates.
The announcement stated that based on its firm confidence in the intrinsic investment value and future development prospects, and comprehensively considering the current operating conditions, financial conditions and other factors, the company plans to use its own funds to repurchase the issued RMB ordinary shares (A shares) in a centralized bidding transaction. All the repurchased shares will be used for cancellation to reduce the company's registered capital.
